BACKGROUND: Physical or psychological adversity in childhood is associated with a higher risk for depression in adulthood, and with persistent serotonergic abnormalities in humans and in animal models. We hypothesized that reported childhood abuse would be associated with lower brain serotonin transporter (5-HTT) binding potential (BP(P), proportional to the number of available transporters) in adults. We examined healthy volunteers and subjects with major depressive disorder, a sample enriched for childhood abuse. METHODS: Regional brain 5-HTT BP(P) was measured using positron emission tomography (PET) with [(11)C]McN 5652 and a metabolite-corrected arterial input function in 43 healthy volunteers and 23 subjects in a major depressive episode, ten of whom reported a history of sexual and/or physical abuse before age 15, and 13 of whom did not. As only two healthy volunteers reported childhood abuse, primary analyses were restricted to the depressed sample, with healthy controls presented as comparators. RESULTS: Depressed subjects reporting childhood abuse had lower 5-HTT BP(P) than nonabused depressed subjects across all brain regions examined (P = 0.017). The groups did not differ in relevant demographic or clinical variables. Genotype frequencies of a functional polymorphism in the 5-HTT gene promoter (5-HTTLPR) did not differ between the groups. CONCLUSIONS: Reported childhood abuse is associated with lower 5-HTT BP(P) in this sample of subjects with major depression, consistent with other reports that childhood adversity can lower serotonergic function permanently. Lower 5-HTT BP(P) may represent a biological pathway through which early life stress predisposes to the development of subsequent psychiatric illness, including major depressive disorder.
BACKGROUND: Physical or psychological adversity in childhood is associated with a higher risk for depression in adulthood, and with persistent serotonergic abnormalities in humans and in animal models. We hypothesized that reported childhood abuse would be associated with lower brain serotonin transporter (5-HTT) binding potential (BP(P), proportional to the number of available transporters) in adults. We examined healthy volunteers and subjects with major depressive disorder, a sample enriched for childhood abuse. METHODS: Regional brain 5-HTT BP(P) was measured using positron emission tomography (PET) with [(11)C]McN 5652 and a metabolite-corrected arterial input function in 43 healthy volunteers and 23 subjects in a major depressive episode, ten of whom reported a history of sexual and/or physical abuse before age 15, and 13 of whom did not. As only two healthy volunteers reported childhood abuse, primary analyses were restricted to the depressed sample, with healthy controls presented as comparators. RESULTS: Depressed subjects reporting childhood abuse had lower 5-HTT BP(P) than nonabused depressed subjects across all brain regions examined (P = 0.017). The groups did not differ in relevant demographic or clinical variables. Genotype frequencies of a functional polymorphism in the 5-HTT gene promoter (5-HTTLPR) did not differ between the groups. CONCLUSIONS: Reported childhood abuse is associated with lower 5-HTT BP(P) in this sample of subjects with major depression, consistent with other reports that childhood adversity can lower serotonergic function permanently. Lower 5-HTT BP(P) may represent a biological pathway through which early life stress predisposes to the development of subsequent psychiatric illness, including major depressive disorder.
Authors: René Hummerich; Oliver Schulze; Thomas Rädler; Pal Mikecz; Matthias Reimold; Winfried Brenner; Malte Clausen; Patrick Schloss; Ralph Buchert Journal: Nucl Med Biol Date: 2006-03-09 Impact factor: 2.408
Authors: Dara M Cannon; Masanori Ichise; Denise Rollis; Jacqueline M Klaver; Shilpa K Gandhi; Dennis S Charney; Husseini K Manji; Wayne C Drevets Journal: Biol Psychiatry Date: 2007-08-02 Impact factor: 13.382
Authors: Dario Maestripieri; J Dee Higley; Stephen G Lindell; Timothy K Newman; Kai M McCormack; Mar M Sanchez Journal: Behav Neurosci Date: 2006-10 Impact factor: 1.912
Authors: Xianzhang Hu; Gabor Oroszi; Jeffrey Chun; Tom L Smith; David Goldman; Marc A Schuckit Journal: Alcohol Clin Exp Res Date: 2005-01 Impact factor: 3.455
Authors: Gregory M Sullivan; Maria A Oquendo; Norman Simpson; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Biol Psychiatry Date: 2005-07-22 Impact factor: 13.382
Authors: Carolyn Cidis Meltzer; Julie C Price; Chester A Mathis; Meryl A Butters; Scott K Ziolko; Eydie Moses-Kolko; Sati Mazumdar; Benoit H Mulsant; Patricia R Houck; Brian J Lopresti; Lisa A Weissfeld; Charles F Reynolds Journal: Neuropsychopharmacology Date: 2004-12 Impact factor: 7.853
Authors: Maria A Oquendo; Ramin S Hastings; Yung-Yu Huang; Norman Simpson; R Todd Ogden; Xian-Zhang Hu; David Goldman; Victoria Arango; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Arch Gen Psychiatry Date: 2007-02
Authors: Louisa J. Steinberg; Mark D. Underwood; Mihran J. Bakalian; Suham A. Kassir; J. John Mann; Victoria Arango Journal: J Psychiatry Neurosci Date: 2019-09-01 Impact factor: 6.186
Authors: Jeffrey M Miller; Benjamin A Everett; Maria A Oquendo; R Todd Ogden; J John Mann; Ramin V Parsey Journal: Synapse Date: 2015-10-19 Impact factor: 2.562
Authors: Jeffrey M Miller; Natalie Hesselgrave; R Todd Ogden; Gregory M Sullivan; Maria A Oquendo; J John Mann; Ramin V Parsey Journal: Biol Psychiatry Date: 2013-03-01 Impact factor: 13.382
Authors: Luis C Reis; André S Mecawi; Verónica Trujillo; Evandro Valentim-Lima; Rodrigo Mencalha; Quézia S R Carbalan; Raoni C Dos-Santos; Viviane Felintro; Carlos E N Girardi; Rodrigo Rorato; Danilo Lustrino Journal: Mol Neurobiol Date: 2020-10-20 Impact factor: 5.590
Authors: Katherine L Gardner; Matthew W Hale; Stafford L Lightman; Paul M Plotsky; Christopher A Lowry Journal: Brain Res Date: 2009-09-23 Impact factor: 3.252